Editorial Board member Fernando Pérez-Ruiz highlights recent clinical trials evaluating the effect of febuxostat on risk of cardiovascular comorbidities, and discusses alternative treatments for gout patients with cardiovascular disease.
Perez Ruiz et al. observe a 50% improvement in targeting therapeutic serum urate following changes to the main European League Against Rheumatism recommendations on the diagnosis and treatment of gout.
Perez Ruiz F et al. Rheumatol Ther 2017. doi: 10.1007/s40744-017-0091-1
Baer et al determine that a dual-energy computed tomography (DECT) scanning protocol that includes all lower extremity joints has moderate sensitivity in non-tophaceous and high sensitivity in tophaceous gout.
Baer AN et al. BMC Musculoskelet Disord 2016;17:91. doi:10.1186/s12891-016-0943-9